Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
2020 · The Lancet · 1,124 citations
https://doi.org/10.1016/s0140-6736(20)31792-x
D
David S. Owens
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
123
Papers
8.4K
Citations
35
h-index
59
i10-index
David S. Owens is an academic researcher from University of Washington. The author has contributed to research in topics: Cardiovascular Effects of Exercise & Cardiac Valve Diseases and Treatments & Cardiac Imaging and Diagnostics. The author has an h-index of 35, co-authored 105 publications.
ORCID: 0000-0002-7293-9688Papers by this author
worksGenetic Associations with Valvular Calcification and Aortic Stenosis
2013 · New England Journal of Medicine · 949 citations
https://doi.org/10.1056/nejmoa1109034
International Recommendations for Electrocardiographic Interpretation in Athletes
2017 · Journal of the American College of Cardiology · 584 citations
https://doi.org/10.1016/j.jacc.2017.01.015
Incidence, Cause, and Comparative Frequency of Sudden Cardiac Death in National Collegiate Athletic Association Athletes
2015 · Circulation · 548 citations
https://doi.org/10.1161/circulationaha.115.015431
International recommendations for electrocardiographic interpretation in athletes
2016 · European Heart Journal · 394 citations
https://doi.org/10.1093/eurheartj/ehw631
Performance of the American Heart Association (AHA) 14‐Point Evaluation Versus Electrocardiography for the Cardiovascular Screening of High School Athletes: A Prospective Study
2019 · Journal of the American Heart Association · 117 citations
https://doi.org/10.1161/jaha.119.012235
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat